Click Fraud Protection Pharmacy Owners Convicted for Multimillion-Dollar Telemedicine Fraud Scheme
TZ Legal – Fraud Fighters Logo
HomeNews66,000 Prescriptions in 3 Years: Pharmacy Owners Convicted for Multimillion-Dollar Telemedicine Fraud Scheme

66,000 Prescriptions in 3 Years: Pharmacy Owners Convicted for Multimillion-Dollar Telemedicine Fraud Scheme

Date Published
May 24, 2022

May 24, 2022. Telemedicine for prescribing pharmaceuticals is supposed to bring convenient care to patients, not be a new way to deal drugs. A multi-year investigation concluded in a criminal trial, with two leaders of a multimillion-dollar telemedicine pharmacy fraud scheme paying approximately $50 million in restitution and facing 17 years in prison. A group of eight co-conspirators schemed to defraud pharmacy benefit managers (PBMs) of tens of thousands of prescriptions, for which the PBMs submitted claims to private and federally-funded health insurance programs. The fraudsters captured profits from their false claims because the PBMs paid claims to pharmacies owned by the co-conspirators, according to court documents. A whistleblower at one of the pharmacies or PBMs could have reported this scheme. Whistleblowers filing successful qui tam lawsuits may receive 15-25% of the government’s recovery.

According to court documents, this large-scale fraud scheme entailed several pharmacy owners hiring a telemarketer to drum up prescriptions for their pharmacies. The telemarketer duped the people it cold-called into accepting prescriptions and obtained their health insurance information in order to submit claims. The telemarketer paid physicians to sign off on the prescriptions without any patient interaction. One of the defendants even “selected specific medications for the prescriptions that he could submit for profitable reimbursements at inflated prices,” gaming the PBM system. In three years, the co-conspirators sought reimbursement for at least 60,000 invalid prescriptions.

The Special Agent in Charge of the FDA Office of Criminal Investigations (OCI) Miami Field Office commented about the seriousness of the case, “Distributing misbranded prescription drugs in the U.S. marketplace places patients’ health at risk.” The Special Agent in Charge of the Department of Health and Human Services, Office of Inspector General (HHS-OIG) also added, “Providers who solicit beneficiaries’ personal information and use it to defraud federal health care programs not only undermine the integrity of those programs; they also divert valuable taxpayer dollars for self-serving purposes.”

Prescription fraud costs both taxpayers and participants in private health insurance plans in the form of increased premiums to cover carriers’ losses and increased scrutiny when medications are prescribed legitimately. Abuse of telemedicine systems erodes provider and patient trust that scrupulous healers and truly needy patients are meeting safely and securely through technology.

A whistleblower can report pharmaceutical fraud and Medicare and Medicaid fraud to the government and be rewarded for doing so in a qui tam lawsuit.

If you would like to report healthcare fraud, you can contact attorneys at Tycko & Zavareei LLP. Eva Gunasekera and Renée Brooker are former officials of the United States Department of Justice and prosecuted whistleblower cases under the False Claims Act. Eva was the Senior Counsel for Health Care Fraud. Renée served as Assistant Director at the United States Department of Justice, the office that supervises False Claims Act cases in all 94 United States District Courts. Eva and Renée now represent whistleblowers. For a free consultation, you can contact Eva Gunasekera at [email protected] or contact Renée at [email protected] (tel.: 202-417-3664). Visit Tycko & Zavareei LLP’s website for whistleblowers to learn more at

How can we help you?

Confidential Case Evaluation

Our experienced qui tam attorneys are available for a confidential, no-cost, no-commitment, initial evaluation of your case. Call us now at (202) 973-0900, or begin the process by completing our Confidential Case Evaluation Form.
Start The Process